Chinese Japanese Germany Korea

Tofacitinib Impurity 69

Tofacitinib Impurity 69 Structure
Tofacitinib Impurity 69 structure
CAS No.
Chemical Name:
Tofacitinib Impurity 69
Synonyms
Tofacitinib Impurity 69
CBNumber:
CB44657804
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
Request For Quotation

Tofacitinib Impurity 69 Preparation Products And Raw materials

Raw materials

Preparation Products

Tofacitinib Impurity 69 Suppliers

Global( 5)Suppliers
Supplier Tel Email Country ProdList Advantage
Shenzhen SUNGENING Bio-Medical Co., Ltd. 0755-28967200 13631290199 wxf@sungening.com China 9506 60
Hubei Moco Chemical Co., Ltd. 18627756402 3001051413@qq.com China 10014 58
Cato Research Chemicals Inc. 020-81215950 4000-868-328 customer@uwalab.com United States 10413 58
Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd 755-22677922-801 18126518403 2851922760@qq.com China 5043 58
Changzhou Xianglong Pharmaceutical Technology Co., LTD 18661161657 yaoxiangqiu2021@163.com China 10066 58
Supplier Advantage
Shenzhen SUNGENING Bio-Medical Co., Ltd. 60
Hubei Moco Chemical Co., Ltd. 58
Cato Research Chemicals Inc. 58
Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd 58
Changzhou Xianglong Pharmaceutical Technology Co., LTD 58

(Tofacitinib Impurity 69)Related Search:

3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI) (3S,4S)-Tofacitinib 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)- N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile 2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE Tofacitinib Impurity 6

1of4

Tofacitinib Impurity 69